These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 38952053

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A long term feed supplementation based on phosphate binders in Feline Chronic Kidney Disease.
    Biasibetti E, Martello E, Bigliati M, Biasato I, Cocca T, Bruni N, Capucchio MT.
    Vet Res Commun; 2018 Jun; 42(2):161-167. PubMed ID: 29582226
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic factors in cats with chronic kidney disease.
    King JN, Tasker S, Gunn-Moore DA, Strehlau G, BENRIC (benazepril in renal insufficiency in cats) Study Group.
    J Vet Intern Med; 2007 Jun; 21(5):906-16. PubMed ID: 17939542
    [Abstract] [Full Text] [Related]

  • 28. Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review.
    Summers S, Michael HT, Szlosek D, Mack R.
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241234984. PubMed ID: 38682929
    [Abstract] [Full Text] [Related]

  • 29. Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease.
    Geddes RF, Elliott J, Syme HM.
    J Vet Intern Med; 2015 Apr; 29(6):1494-501. PubMed ID: 26403212
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Investigation of the transforming growth factor-beta 1 signalling pathway as a possible link between hyperphosphataemia and renal fibrosis in feline chronic kidney disease.
    Lawson JS, Syme HM, Wheeler-Jones CPD, Elliott J.
    Vet J; 2021 Jan; 267():105582. PubMed ID: 33375963
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ionized hypercalcemia in 238 cats from a referral hospital population (2009-2019).
    Broughton SE, O'Neill DG, Syme HM, Geddes RF.
    J Vet Intern Med; 2023 Jan; 37(1):80-91. PubMed ID: 36645022
    [Abstract] [Full Text] [Related]

  • 36. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
    Harjes LM, Parker VJ, Dembek K, Young GS, Giovaninni LH, Kogika MM, Chew DJ, Toribio RE.
    J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Magnesium: An old player revisited in the context of CKD-MBD.
    Pendón-Ruiz de Mier MV, Rodelo-Haad C, Díaz-Tocados JM, Muñoz-Castañeda JR, Rodríguez M.
    Clin Chim Acta; 2020 Feb; 501():53-59. PubMed ID: 31836501
    [Abstract] [Full Text] [Related]

  • 39. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
    Malhotra R, Katz R, Hoofnagle A, Bostom A, Rifkin DE, Mcbride R, Probstfield J, Block G, Ix JH.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):36-44. PubMed ID: 29208626
    [Abstract] [Full Text] [Related]

  • 40. Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.
    Hardy BT, de Brito Galvao JF, Green TA, Braudaway SR, DiBartola SP, Lord L, Chew DJ.
    J Vet Intern Med; 2015 Jan 06; 29(1):200-6. PubMed ID: 25619515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.